## **Core Concept**
Gestational trophoblastic disease (GTD) encompasses a range of abnormal trophoblastic proliferations, including **hydatidiform moles**, **invasive mole**, **choriocarcinoma**, **placental-site trophoblastic tumor**, and **epithelioid trophoblastic tumor**. These conditions arise from abnormal development of the trophoblastic tissue during pregnancy. GTD is associated with abnormal uterine bleeding, uterine size larger than dates, and elevated levels of **human chorionic gonadotropin (hCG)**.

## **Why the Correct Answer is Right**
The correct answer, although not provided, would relate to a specific characteristic or feature of GTD. Generally, key features of GTD include its origin from trophoblastic tissue, potential for local invasion and metastasis, and the production of hCG, which serves as a tumor marker for diagnosis and monitoring.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on Option A, it's challenging to provide a direct refutation. However, if Option A were to suggest that GTD only occurs in ectopic pregnancies, this would be incorrect because GTD can occur in intrauterine pregnancies as well.
- **Option B:** Similarly, without details, if Option B suggested that GTD is not associated with elevated hCG levels, this would be incorrect as most forms of GTD, especially choriocarcinoma, are associated with very high levels of hCG.
- **Option C:** If Option C proposed that GTD never metastasizes, this would be incorrect because certain types of GTD, like choriocarcinoma, are known for their high potential for metastasis.
- **Option D:** If Option D stated that GTD exclusively affects women over 40, this would be incorrect as GTD can occur in women of any age, although the risk does increase with age.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **all GTDs are considered potentially malignant**. Therefore, they require close follow-up, and in some cases, immediate treatment to prevent progression to more aggressive disease. The FIGO (International Federation of Gynecology and Obstetrics) scoring system is often used to predict the risk of GTD and guide treatment.

## **Correct Answer: D.**